10.07.2015 Views

Systematic review, meta-analysis and economic modelling of ...

Systematic review, meta-analysis and economic modelling of ...

Systematic review, meta-analysis and economic modelling of ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

DOI: 10.3310/hta17010 Health Technology Assessment 2013 Vol. 17 No. 1TABLE 24 Prognostic accuracy <strong>of</strong> biomarkers in troponin-negative patientsStudy Biomarker ThresholdBiomarkerpositiveBiomarkernegativeRRPonitz 2009 116 BNP Quartiles NR NR NR aBholasingh 2003 89 CRP > 0.3 mg/dl 8/135 3/236 4.7 (95% CI 1.3 to 17.3)Brennan 2003 91 CRP Quartiles NR NR NR bMenown 2003 113 CRP Quartiles NR NR NR cPonitz 2009 116 CRP Quartiles NR NR NR aEggers 2008 97 GRF-15 1200 ng/l 8/201 1/117 4.7 (95% CI 0.6 to 36.8)1800 ng/l 8/104 1/204 15.6 (95% CI 2.0 to 124)Ilva 2009 50 H-FABP 10.4 µg/l 6/28 11/159 3.1 (95% CI 1.2 to 7.7)Viswanathan 2010 121 H-FABP 6.48 µg/l 10/35 30/721 6.9 (95% CI 3.7 to 12.9)Menown 2003 113 Interleukin 6 Quartiles NR NR NR cCollinson 2006 48 IMA 85 kU/l 11/279 2/139 2.7 (95% CI 0.6 to 12.2)Apple 2007 87 MPO 125.6 µg/l 9/240 6/150 0.9 (95% CI 0.3 to 2.6)Apple 2011 88 MPO 633 pmol/l Unable toextractUnable toextractUnable to extract dBrennan 2003 91 MPO Quartiles NR NR NR bApple 2007 87 NT-pro-BNP < 75 years, 125 ng/l;≥ 75 years, 450 ng/l13/245 2/142 3.8 (95% CI 0.9 to 16.5)Lund 2003 107 PAPP-A 2.9 mIU/l 20/61 6/75 4.1 (95% CI 1.8 to 9.6)GRF-15, growth differentiation factor 15; NR, not reported.a Multivariate HR reported (see Table 23).b Multivariate OR reported (see Table 23).c Univariate OR reported (see Table 22).d Reported as 18.1% vs 5.0% (p < 0.002).only started to be used in patients presenting to hospital with acute pain many years after its diagnosticaccuracy for CAD had been evaluated in patients with stable chest pain.Diagnostic studies <strong>of</strong> computed tomographic coronary angiographyTable 25 shows the characteristics <strong>of</strong> the diagnostic studies that compared CTCA with a reference st<strong>and</strong>ard<strong>of</strong> ICA for CAD. The studies were relatively small (n = 31 to 113). Mean age varied from 53 to 62 years,<strong>and</strong> men outnumbered women in all studies. Most studies explicitly excluded patients with diagnosticECG changes. The threshold for diagnosing obstructive CAD was 50% stenosis in all studies, except for thestudy <strong>of</strong> Sato et al., 129 which used a threshold <strong>of</strong> 75% for both tests.Figure 27 shows the quality assessment <strong>and</strong> Figure 28 the methodological quality summary <strong>of</strong> diagnosticstudies <strong>of</strong> CTCA. Study quality was generally high, although blinding <strong>of</strong> interpretation <strong>of</strong> the index orreference st<strong>and</strong>ard test was unclear or absent in around half <strong>of</strong> the studies.Figure 29 shows the result <strong>of</strong> <strong>meta</strong>-<strong>analysis</strong> <strong>of</strong> CTCA diagnostic studies. The summary estimates <strong>of</strong>sensitivity <strong>and</strong> specificity were 93% (95% predictive interval 61% to 99%) <strong>and</strong> 87% (16% to 100%),respectively. The highest sensitivity <strong>and</strong> specificity was achieved in the only study <strong>of</strong> 64-slice CT. 126 Twostudies 124,125 reported markedly lower specificity. The variation in specificity may be explained by artefact© Queen’s Printer <strong>and</strong> Controller <strong>of</strong> HMSO 2013. This work was produced by Goodacre et al. under the terms <strong>of</strong> a commissioning contract issued by the Secretary <strong>of</strong> Statefor Health. This issue may be freely reproduced for the purposes <strong>of</strong> private research <strong>and</strong> study <strong>and</strong> extracts (or indeed, the full report) may be included in pr<strong>of</strong>essional journalsprovided that suitable acknowledgement is made <strong>and</strong> the reproduction is not associated with any form <strong>of</strong> advertising. Applications for commercial reproduction should beaddressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials <strong>and</strong> Studies Coordinating Centre, Alpha House, University <strong>of</strong> Southampton SciencePark, Southampton SO16 7NS, UK.67

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!